Miquel Tuson was born in Barcelona, Catalonia. He graduated with a BSc from University of Barcelona in 1999, majoring in Biology (Biomedical sciences). He received his doctorate (Biology, Genetics) at the Department of Genetics, University of Barcelona in 2004, with a PhD thesis on inherited retinal dystrophies, which led to the identification of a novel retinitis pigmentosa gene: CERKL. He was a postdoctoral researcher at Kathryn Anderson's laboratory at the Sloan-Kettering Institute in New York (2006-2010), investigating the role of genes encoding cilia-associated proteins during early embryonic development of the mouse central nervous system. Since 2011, he has worked in different genetics and biotechnology companies, focusing in pharmacogenetics applications and genètic diagnosis of rare diseases.